Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyMyelomaTeam Member asked a question 💭
New Jersey City, NJ
August 31, 2025
 · 
Be the first to react
MyMyelomaTeam

While waiting to hear directly from others, here's what research shows about CAR-T therapy outcomes:

• 3 out of 4 people experienced reduced cancer signs and symptoms
• 1 out of 3 people had a complete response (all signs of cancer disappeared)
• Among those with complete response, 2 out of 3 maintained remission for at Show Full Answer

While waiting to hear directly from others, here's what research shows about CAR-T therapy outcomes:

• 3 out of 4 people experienced reduced cancer signs and symptoms
• 1 out of 3 people had a complete response (all signs of cancer disappeared)
• Among those with complete response, 2 out of 3 maintained remission for at least one year The CAR-T process involves:
• Collecting your T cells through a blood filtering process
• Genetically modifying these cells in a lab to target myeloma
• Growing and multiplying these modified cells
• Returning them to your body to fight the cancer

You'll need to stay near the treatment center for about a month after the procedure for monitoring. While most side effects are mild, having the procedure done at a certified center ensures any complications can be properly managed.

August 31, 2025

Related Questions

View All
A MyMyelomaTeam Member asked a question 💭
Taylors, SC

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In